OverT Bio
Cell & Gene Therapy · Biotechnology

OverT Bio news and milestones

OverT Bio: 15 headlines on record, 0 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 17, 2026 · Back to the company report
15Headlines
0In 90 days
2Milestones

Headlines

Aug 172026
Press release · PRNewswire
In the news release, The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators,...
Mar 242026
News · bioworld.com
Overt Bio Inc. is advancing lead asset OVT-101 toward the clinic. The allogeneic, potential first-in-class, off-the-shelf γδ CAR T therapy targets claudin-6, which is present in…
Feb 13, 20252025
News · jpmorgan.com
At J.P. Morgan, our bankers aren't just financial professionals-they're former founders, industry leaders and company builders equipped to guide you from idea to IPO and beyond.
May 16, 20242024
News · Pulse 2.0
OverT Bio (a data-driven company working to unlock the curative potential of cell therapies in solid tumors) has raised $16 million in seed funding. This funding round was co-led…
May 11, 20242024
News · donews.com
OverT Bio是一家肿瘤细胞免疫疗法开发商致力于开发了平行基因筛查、单细胞多组学和合成生物学平台将细胞工程技术与大数据方法相结合以解决实体肿瘤领域未满足的主要医疗需求其核心平台搜 ...
May 6, 20242024
News · PRNewswire
PRN_FinancialWrapper
May 6, 20242024
News · endpoints.news
New York biotech debuts with 16M to find new ways to make solid cancer cell therapies
Nov 22, 20232023
Press release · businesswire.com
OverT Bio Receives 120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

OverT Bio, News. Alion, Nov 17, 2026. https://alion.io/company/overt-bio/news

.json · .md · CC BY-SA 4.0